PlainRecalls
FDA Drug Moderate Class II Terminated

Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-010-16

Reported: May 18, 2022 Initiated: April 1, 2022 #D-0861-2022

Product Description

Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-010-16

Reason for Recall

Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.

Details

Units Affected
885 cartons
Distribution
Nationwide within USA
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-010-16. Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories). Units affected: 885 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 18, 2022. Severity: Moderate. Recall number: D-0861-2022.